Skip to main content
Premium Trial:

Request an Annual Quote

Kenneth Berns, David Botstein, Virgil Elings, David O Bryan, Peter Schwartz

Premium

Kenneth Berns, 64, a professor of genetic research at Mount Sinai Medical Center in New York, has been selected to lead the Genetics Institute at the University of Florida in Gainesville, a multi-disciplinary facility to open in the fall, according to a report in the Gainesville Sun newspaper. Berns left the University of Florida in 2002 to accept the positions of president and CEO of Mount Sinai Medical Center and Mount Sinai Hospital, but was asked to resign in March.

 

David Botstein, the new director of the Lewis-Sigler Institute for Integrative Genomics at Princeton University was presented with the 2003 Genetics prize Thursday at the XIX International Congress of Genetics in Melbourne, Australia. The prize, awarded by the Peter Gruber Foundation, includes a medal and a check for $150,000.

 

Virgil Elings, David O’Bryan, and Peter Schwartz have joined the scientific advisory board of BioForce Nanosciences, of Ames, Iowa. BioForce makes nano-array systems in which atomic force microscopy is used for detection of molecules. Elings is a former physics professor at the University of California, Santa Barbara, where he developed scanning probe microscopy for imaging of individual atoms, and founded Digital Instruments to commercialize this technology. O’Bryan is the managing director of Hibernia Consulting partners. Prior to this, O’Bryan was the senior vice president at SmithKline Beecham Clinical Laboratories. Schwartz is an assistant professor of physics at California Polytechnic State University, San Luis Obispo. He is the inventor of “high force nano-grafting,” a nanolithography technology.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.